. 2019 Autumn;18(Suppl1):269–281. doi: 10.22037/ijpr.2019.112466.13775

Table 1.

Baseline characteristics

			Intervention groups						sig ^a,b,c
			Colistin IV + Colistin Nebulizer			Ampicillin-Sulbactam IV + Colistin Nebulizer
			count	Mean $\pm$ SD ^f	Min–Max	count	Mean $\pm$ SD	Min–Max
Sex	Female		6			6			0.508^a
Sex	Male		10			6			0.508^a
Age				60 $\pm$ 19	22–87		59 $\pm$ 16	32–85	0.859^b
Weight				79 $\pm$ 20	55–120		82 $\pm$ 10	68–98	0.589^b
Lean Body Weight				53.50 $\pm$ 8.98	34.58–70.98		54.48 $\pm$ 9.02	43.41–70.24	0.779^b
ICD10Code^d	T		5			2			0.613^a
	C		2			1
	G		5			5
	J		1			1
	I		1			2
	S		2			0
	K		0			1
APACHEII				15 $\pm$ 4	9–20		16 $\pm$ 5	12–31	0.709^c
ampicillin-sulbacatam sensitvity^e		S	4			3			1.00^a
ampicillin-sulbacatam sensitvity^e		R	12			9			1.00^a
PCT base			16	6.06 $\pm$ 18.46		11	1.76 $\pm$ 3.07		0.505^c
intubation period (before recruitment)				16 $\pm$ 12	5–47		13 $\pm$ 4	7–20	0.339^a

^aChi-square; ^bIndependent samples t-test; ^cMann Whitney; ^dICD10 code definition: T = Injuries to unspecified part of trunk, limb or body region, C = Malignant neoplasms, G = Diseases of the nervous system (loss of consciousness, ICH), J = Diseases of the respiratory system, I = Diseases of the circulatory system (cerebrovascular accident, pericardial effusion), S = Injuries to specified part of body, K = Diseases of the digestive system; APACHE II, acute physiologic and chronic health evaluation; ^eampicillin-sulbacatam sensitivity definition: S = Sensitive, R = Intermediate or Resistant; ^fStandard Deviation